Secondary analysis of the SVR trial (549 participants with single ventricle) over 16 years: 87% had death or major morbidity. Outcomes did not differ overall by shunt type but were worse with RVPAS when pre-Norwood tricuspid regurgitation was moderate or severe.
Secondary analysisn = 549
Hill et al. Single-Ventricle Disease: Long-Term Outcomes and Global Morbidity in the Single Ventricle Reconstruction Trial